EP News Bureau

India's Foremost Pharma & Biotech Magazine

The drug is indicated for the maintenance treatment of asthma and as prophylactic therapy in children 12 months to 8 years of age

The loan will allow OPTEL Group to extend its traceability service offer as well as diversify its activities in the healthcare,…

This is the first FDC drug available to patients in India

The patents are valid till 2032, 2030 and 2034

Kwitz helps smokers in smoking cessation and support the individual to achieve a smoke-free life

RSSDI partners with Wellthy Therapeutics to pioneer the adoption of diabetes digital therapeutics in India

To provide financial assistance of Rs 28.99 crores for the development and commercialisation of dengue tetravalent vaccine

Posts gross sales of Rs. 6,590 crores in the same quarter

The conference on Consumer Healthcare in VUCA World will be held in Mumbai